Patent ID: 9017939
Filing Date: 2015-04-28
Classification: A61K,A61P,C12N,C12Q

Abstract:
1. A method of diagnosing whether a subject has, or is at risk for developing, a solid cancer, comprising: receiving a test sample of breast, colon, lung, pancreatic, or prostate tissue extracted from a subject; measuring by Northern blot analysis the level of at least miR-21 and miR-17-5p gene products in the test sample, wherein the Northern blot analysis comprises: comparing the level of at least miR-21 and miR-17-5p gene products in the test sample to a control level of at least miR-21 and miR-17-5p gene products in a control sample of normal corresponding tissue; and diagnosing whether the subject has, or is at risk for developing, a solid cancer other than stomach cancer if the level of at least miR-21 and miR-17-5p gene products in the test sample from the subject is greater than the level of miR-21 and miR-17-5p gene products of the control; wherein: